MEDIFAST Balance Sheet Analysis From 2010 to 2024
MED Stock | USD 32.47 0.59 1.85% |
MEDIFAST |
Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out MEDIFAST INC Valuation and MEDIFAST INC Correlation analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 417.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.66.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 1.1B | 775.9M | 814.6M | Total Revenue | 1.5B | 1.6B | 1.1B | 1.1B |
MEDIFAST INC fundamental ratios Correlations
Click cells to compare fundamentals
MEDIFAST INC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEDIFAST INC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Other Current Liab | 49.3M | 64.3M | 84.4M | 69.1M | 46.6M | 49.0M | |
Net Debt | (63.4M) | (152.6M) | (71.6M) | (61.6M) | (72.4M) | (68.8M) | |
Retained Earnings | 168.8M | 154.4M | 190.3M | 139.9M | 174.6M | 183.4M | |
Cash | 77.0M | 163.7M | 104.2M | 87.7M | 94.4M | 99.2M | |
Net Receivables | 1.0M | 1.4M | 584K | 1.0 | 8.7M | 9.2M | |
Inventory | 48.8M | 53.4M | 180.0M | 118.9M | 54.6M | 27.8M | |
Other Current Assets | 11.3M | 5.9M | 17.3M | 16.2M | 10.7M | 5.5M | |
Total Liab | 89.8M | 118.8M | 195.9M | 161.2M | 108.4M | 113.8M | |
Total Current Assets | 154.2M | 234.3M | 306.9M | 222.8M | 224.0M | 235.2M | |
Short Term Debt | 3.2M | 3.7M | 6.5M | 5.8M | 5.9M | 6.2M | |
Accounts Payable | 22.6M | 35.8M | 70.9M | 58.7M | 39.2M | 21.4M | |
Other Assets | 1.7M | 14.1M | 10.9M | 17.8M | 20.5M | 21.5M | |
Net Tangible Assets | 104.8M | 157.2M | 202.5M | 155.0M | 178.3M | 125.0M | |
Capital Surpluse | 0.0 | 7.8M | 12.0M | 21.6M | 19.4M | 10.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Valuation and MEDIFAST INC Correlation analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.